Back
NM_000546.5:c.105G>T
p.Leu35Phe · TP53
0%
complete
Final classification
Likely Benign
PM2BS3BP4
TP53
c.105G>T
p.Leu35Phe
This variant

The TP53 c.105G>T (p.Leu35Phe, p.L35F) variant has been reported in ClinVar as a variant of uncertain significance by the ClinGen TP53 Variant Curation Expert Panel.

Transcript
NM_000546.5
HGVS · transcript:coding
NM_000546.5:c.105G>T
GRCh38
chr17:7676264 C>A
GRCh37
chr17:7579582 C>A
TP53 VCEP v2.4.0 Tavtigian point-based final-classification framework from the official CSPEC/VCEP ruleset
Classification rationale
PM2 BS3BP4 Likely Benign
TP53 c.105G>T

The TP53 c.105G>T (p.Leu35Phe, p.L35F) variant has been reported in ClinVar as a variant of uncertain significance by the ClinGen TP53 Variant Curation Expert Panel.1 This variant is absent from gnomAD v2.1 and gnomAD v4.1, supporting marked rarity in population databases.2 In the TP53 functional evidence framework, p.L35F is listed as functional with no loss of function, supporting BS3 and arguing against PS3.3 Computational evidence does not support a damaging effect: SpliceAI predicts no splice impact with a max delta score of 0.00, BayesDel is -0.0784713, REVEL is 0.486, and the TP53 bioinformatic worksheet assigns BP4_moderate.4

PM2 + BS3 + BP4 Likely Benign
3 vcep_functional_worksheetvcep_flowchart_for_application_of_functional_rule_codes
4 spliceai ↗bayesdelrevelvcep_pp3_bp4_codesvcep_flowchart_for_application_of_pp3_2c_bp4_2c_and_bp7
LYFE Sciences is an AI system, and it can make mistakes. Criteria may be applied incorrectly, sources may be misread, and a confident-looking classification can still be wrong. Double-check every criterion and its underlying evidence before relying on any call.
Gene diagram · NM_000546.5 · variants mapped to exon structure
TP53 NM_000546.5
Fetching transcript structure from UCSC…
Applied criteria · 3 applied · 13 assessed
MetEvidence satisfies this criterion.
Not metEvaluated against available evidence; threshold not reached.
Not assessedApplies in principle, but no evidence was found to evaluate it.
N/ADoesn't apply to this variant type.
Applied · 3
Strength Supporting Moderate Strong Very strong
PM2 supporting Pathogenic
This variant is absent from gnomAD v2.1 and gnomAD v4.1, corresponding to an observed allele frequency of 0, which is below the TP53 VCEP PM2 threshold of less than 0.00003 overall and below the per-ancestry threshold of less than 0.00004.
Absent from gnomAD v2.1Absent from gnomAD v4.1
BS3 strong Benign
Available TP53 functional evidence supports retained function rather than loss of function. The TP53 functional worksheet lists p.L35F as functional with no loss of function and assigns BS3.
Functional worksheet entry: L35FFunctionalnoLOF
BP4 moderate Benign
Available computational evidence supports a benign prediction under the TP53 VCEP framework. SpliceAI predicts no splice effect with a max delta score of 0.00, BayesDel is -0.0784713, which is at or below the TP53 VCEP BP4_Moderate threshold of -0.008, and the TP53 bioinformatic worksheet assigns BP4_moderate for c.105G>T. REVEL is 0.486 and does not change the TP53 VCEP-specific BP4 assignment.
SpliceAI max delta 0.00BayesDel -0.0784713REVEL 0.486
Assessed · not applied · 5 not met · 8 not assessed
Pathogenic
PS1 No reviewed evidence was identified showing that another nucleotide change causing the same amino acid substitution has already been classified as pathogenic or likely pathogenic under the TP53 VCEP framework.
PS2 No confirmed de novo occurrence with adequate parental testing and TP53 VCEP point-based scoring was identified for this variant.
PS3 Available TP53 functional evidence does not support a damaging loss-of-function effect for this variant.
PS4 The variant meets PM2_Supporting based on population rarity, but no TP53 VCEP case-point evidence was identified to show enrichment in affected individuals.
PM1 Available evidence does not support this variant as occurring in a TP53 mutational hotspot or other critical region qualifying for PM1.
PM5 No reviewed evidence was identified showing that other missense variants at codon 35 have already been classified as pathogenic or likely pathogenic under the TP53 VCEP framework at the strengths required for PM5.
PP1 No segregation data were identified for this variant, so the number of informative meioses required for TP53 VCEP PP1 scoring could not be determined.
PP3 Available computational evidence does not support a damaging prediction under the TP53 VCEP framework.
PP4 No blood variant allele fraction or mosaicism-focused clinical observations were identified to apply the TP53 VCEP PP4 rule.
Benign
BA1 This variant is absent from gnomAD v2.1 and gnomAD v4.1, so its observed allele frequency of 0 is below the TP53 VCEP BA1 threshold of at least 0.001.
BS1 This variant is absent from gnomAD v2.1 and gnomAD v4.1, so its observed allele frequency of 0 is below the TP53 VCEP BS1 threshold of at least 0.0003.
BS2 No source was identified showing the number of unrelated females aged 60 years or older without cancer who carry this variant, so BS2 could not be assessed.
BS4 No family data were identified showing lack of segregation with Li-Fraumeni syndrome-associated cancers, so BS4 could not be assessed.
N/A · 12 PVS1 · PM3 · PM4 · PM6 · PP2 · PP5 · BP1 · BP2 · BP3 · BP5 · BP6 · BP7
Research & evidence
Population frequency · supports benign
gnomAD v4.1 screenshot
gnomAD v4.1
gnomAD v2.1 screenshot
gnomAD v2.1
v4.1
Absent from gnomAD v4.1.
v2.1
Absent from gnomAD v2.1.
Allele frequency by ancestry
three datasets · side by side
gnomAD v4.1
Absent · 0 / ?
0 hom
Not observed in any ancestry group.
gnomAD v2.1
Absent · 0 / ?
0 hom
Not observed in any ancestry group.
ClinVar screenshot
ClinVar
This variant has been reported in ClinVar as Uncertain Significance by ClinGen TP53 Variant Curation Expert Panel, ClinGen (expert panel).
SpliceAI screenshot
In silico
SpliceAI predicts no significant splice impact for this variant (max delta score = 0.00). REVEL score = 0.486. BayesDel score = -0.0784713.
Functional / OncoKB screenshot
Functional Unknown Oncogenic Effect
OncoKB did not identify variant-specific reviewed functional evidence for this variant; gene-level curated context is available for reviewer follow-up. TP53, a tumor suppressor in the DNA damage pathway, is the most frequently mutated gene in cancer.
OncoKB ↗
COSMIC screenshot
COSMIC
Cancer hotspots screenshot
Cancer hotspots
Somatic evidence Not in COSMIC / hotspots
COSMIC
This variant does not lie in a statistically significant hotspot. This variant has previously been reported in somatic cancers (COSMIC; COSV53176324, n = 2 times).
Hotspots
This variant does not lie in a statistically significant hotspot.
Sources & reference links
8Sources
CSpec VCEP
ClinVar
gnomAD v2.1
gnomAD v4.1
SpliceAI
OncoKB
COSMIC
Cancer hotspots